Introduction
Hyperinsulinemia is associated with increased morbidity and mortality for cardiovascular complications in patients with obesity of central type. 1 Moreover hyperinsulinemia and insulin-resistance syndrome were linked with microalbuminuria (MA) together with other metabolic and endocrine abnormalities (eg alterations of NEFA, blood glucose, lipoproteins and glucagon). Within this context, glucagon might contribute to determine MA by means of its own activity on renal hemodynamic function and in particular by in¯uencing glomerular ®ltration rate (GFR). 2 Therefore the present study was undertaken to evaluate the role of insulin and glucagon in the¯uctuations of albuminuria and of GFR in obese patients with peripheral and central fat distribution.
Subjects and methods
The study concerned 11 healthy subjects (age range 27 ± 51 y, BMI range 19 ± 23 kgam 2 ), 18 normotensive patients with peripheral obesity (age range 25 ± 53 y, BMI range 28 ± 44 kgam 2 , WHR range 0.75 ± 0.84) and 22 normotensive patients with central obesity (age range 28 ± 55 y, BMI range 32 ± 44 kgam 2 , WHR range 0.97 ± 1.05). Serum insulin and glucagon were determined (RIAs, DPC Los Angeles, CA) fasting and 1 h, 2 h after OGTT (75 g orally). GFR was determined by single intravenous injection of 2 mCi of 99 m Tc-DTPA. Urinary albumin (AER) and IgG (IgGER) excretion rates were measured by nephelometry (BNA, Behringwerke AG, Marburg, Germany).
3 Plasma NEFA were determined by a colorimetric method. Table 1 summarizes clinical, biochemical, metabolic and hormonal parameters evaluated in healthy subjects and in obese patients. Higher insulin and glucagon levels (at baseline and during OGTT), GFR and NEFA were found in patients with central obesity than in healthy subjects and in patients with peripheral obesity. Serum glucagon levels (fasting and 60 min after OGTT) were also correlated with the increase of GFR in patients with central obesity (r 0.49, P`0.05 and r 0.58, P`0.01 respectively), whereas no correlations were found between insulin and GFR in this group. AER and IgGER were signi®cantly higher in patients with central obesity than in healthy subjects and in patients with peripheral obesity.
Results

Discussion
As previously suggested, 4 hyperinsulinemia was associated with increased serum glucagon concentrations and NEFA levels in patients with central obesity. The increase of glucagon was also correlated with GFR, that was higher in patients with central obesity than in healthy subjects and in patients with obesity of peripheral type. The link between glucagon and GFR may be dependent on several well known mechanisms 2 and may have important consequences on glomerular permeability. In fact, the hemodynamic action of glucagon on GFR may potentially alter the permselective properties of glomerular basement mem-brane to serum proteins, 5 increasing AER and IgGER in patients with central obesity. MA and leakage of IgG may therefore be the expression of incipient vascular derangement and may contribute to enhance the cardiovascular risk of patients with obesity of central type. Finally, the deposition of albumin and IgG into glomerular microvasculature might induce the development of renal hypertension, so contributing to extend the progression of vascular damage in obese patients.
